BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Autoimmunity
,
Rosiglitazone
,
rs3825942
,
CYP51
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
transforming growth factor beta receptor activity, type II
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bladder
Tongue superior part with papillae
Tonsil
Bone marrow
Pharyngeal mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Pseudohermaphroditism
Situs inversus viscerum
Immunoglobulin G4 deficiency
Vitamin D deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
tizanidine
CGP 60474
Glesatinib
ACY 1215
OTS-167
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir129
RBKS
EZR
PPP2R2C
BMPR2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for transforming growth factor beta receptor activity, type II
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Angiotensin II Antagonism of TGF-Beta 1
Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Tr…
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, …
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Tr…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ